22/12/2014 02:44:13 Free Membership Login

   

Array

Visual Financials
Company Name: Array BioPharma, Inc.
Ticker Symbol: ARRY
WWW Address: http://www.arraybiopharma.com
CEO: Ron Squarer
No. of Employees: 265
Common Issue Type: CS
Business Description:Array BioPharma, Inc., is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 4.87 Up 0.06 4.86 4.96 4.79 4.94 4.76 6055179
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 642.7 132.0 0.00 -0.69 0.00 0.0 0.0 5.64 - 2.98
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close4.86$
PE Ratio - LTM0.0
Market Capitalisation642.7mil
Latest Shares Outstanding132.0mil
Earnings pS (EPS)-0.69$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float103.1mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue1.20%
Gross Profit Margin-9.2%
EBITDA Margin-168.8%
Pre-Tax Profit Margin-202.6%
Assets Turnover30.6%
Return on Assets (ROA)-62.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio2.3
Leverage Ratio (Assets/Equity)
Interest Cover-7.8
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.52$
Cash pS0.00$
Book-Value pS-0.28$
Tangible Book-Value pS-0.19$
Cash Flow pS-0.70$
Free Cash Flow pS-0.73$
KEY FIGURES (LTM): Price info
Price/Book Ratio-17.06
Price/Tangible Book Ratio0.00
Price/Cash Flow-6.9
Price/Free Cash Flow-6.7
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---5.495.28-2-1
4 Weeks4.944.764.765.495.28528
13 Weeks4.864.8660470253.515.64528
26 Weeks60470255.495.493.535.64536
52 Weeks3.723.723.765.492.98436
YTD2.982.98-5.492.982-1
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
2.982.983.773.775.491.581.58
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue722740344457739644577396
Income7227403472274034129172820
Dividend129172820222488343222488343
Capital Spending415333356NA415333356
R&D66277214NA66277214
Normalized Inc.129172820NA129172820
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %3-20-20
Earnings %-16-16-15
EPS %85109109
EPS $-157373
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio139053000
Quick Ratio (Acid Test)17377000
Liquidity Ratio (Cash)0.00
Receivables Turnover9932000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS-25721000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)6953000
Debt Ratio164774000
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity640000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities164774000
Interest Cover-82290000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM223,439,672.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-29.43
Dividend Yield12895349
Price/Tangible Book Ratio - LTM54
Price/Book Ratio - LTM1646452
Price/Cash Flow Ratio2.3
Price/Free Cash Flow Ratio - LTM54
Price/Sales Ratio23.00
P/E Ratio (1 month ago) - LTM223439672
P/E Ratio (26 weeks ago) - LTM336261087
P/E Ratio (52 weeks ago) - LTM336261087
5-Y High P/E Ratio416552503
5-Y Low P/E Ratio404176848
5-Y Average P/E Ratio3078191
Current P/E Ratio as % of 5-Y Average P/E3078191
P/E as % of Industry Group3,613,701.0
P/E as % of Sector Segment3,613,701.0
Current 12 Month Normalized P/E Ratio - LTM4,052,490.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM2.3
Book Value pS - LTM1646452
Capital Invested pS0.00
Cash pS - LTM35240
Cash Flow pS - LTM6.36
Free Cash Flow pS - LTM6.36
Earnings pS (EPS)-24
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-82290000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)-25721000
Return on Equity (ROE) - 5YEAR AVRG.641341691
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-93
Assets Productivity6,953,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.641341691
Gross Profit Margin3613701
Gross Profit Margin - 5YEAR AVRG.-93
EBITDA Margin - LTM1987274
EBIT Margin - LTM3613701
Pre-Tax Profit Margin8157000
Pre-Tax Profit Margin - 5YEAR AVRG.131963311
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle52,733,522
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover9932000
Day's Inventory Turnover Ratio52733000
Inventory Turnover9932000
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover6953000
Revenue per $ Cash19693000
Revenue per $ Plant19693000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.131963311
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq arry141222 02:44